Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The dopamine receptor D2 (D2R) is a G protein-coupled receptor (GPCR) that mediates dopaminergic neurotransmission, particularly within the central nervous system. The postsynaptic D2 receptor couples to Gi/o proteins, inhibiting adenylyl cyclase activity and decreasing cyclic AMP levels. It plays a key role in regulating neurotransmitter release, synaptic plasticity, motor control, reward processing, and is a major target for antipsychotic drugs. Alterations in postsynaptic D2R signaling are implicated in schizophrenia, Parkinson’s disease, drug addiction, and ADHD.
Antagonism or agonism of the dopamine D2 receptor, influencing downstream signaling pathways.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dopamine Receptor D2 (Postsynaptic) (D2R).